Cargando…

Complete recovery of fulminant cytotoxic CD8 T‐cell‐mediated myocarditis after ECMELLA unloading and immunosuppression

A 19‐year‐old woman with no previous cardiac history was admitted to the hospital with third‐degree atrioventricular block and left ventricular dysfunction. Her condition quickly deteriorated to severe biventricular failure and cardiogenic shock requiring mechanical circulatory support. An endomyoca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jurcova, Ivana, Rocek, Jan, Bracamonte‐Baran, William, Zelizko, Michael, Netuka, Ivan, Maluskova, Jana, Kautzner, Josef, Cihakova, Daniela, Melenovsky, Vojtech, Maly, Jiri
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373888/ https://www.ncbi.nlm.nih.gov/pubmed/32485066 http://dx.doi.org/10.1002/ehf2.12697

Ejemplares similares

Mechanical Unloading by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA, and PROPELLA Concepts
por: Tschöpe, Carsten, et al.
Publicado: (2018)

Short-term use of “ECMELLA” in the context of fulminant eosinophilic myocarditis with cardiogenic shock
por: Bohné, Mintje, et al.
Publicado: (2020)

Pulmonary Vasculature Responsiveness to Phosphodiesterase-5A Inhibition in Heart Failure With Reduced Ejection Fraction: Possible Role of Plasma Potassium
por: Monzo, Luca, et al.
Publicado: (2022)

Innate Lymphoid Cells Play a Pathogenic Role in Pericarditis
por: Choi, Hee Sun, et al.
Publicado: (2020)

Fulminant eosinophilic myocarditis treated with steroids and mechanical unloading: a case report
por: Balthazar, Tim, et al.
Publicado: (2020)

Trajectories and determinants of left ventricular ejection fraction after the first myocardial infarction in the current era of primary coronary interventions
por: Wohlfahrt, Peter, et al.
Publicado: (2022)

Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support
por: Nakashima, Hiroshi, et al.
Publicado: (2013)

Attenuation of Hypocretin/Orexin Signaling Is Associated With Increased Mortality After Myocardial Infarction
por: Wohlfahrt, Peter, et al.
Publicado: (2023)

B-type natriuretic peptide: powerful predictor of end-stage chronic heart failure in individuals with systolic dysfunction of the systemic right ventricle
por: Hegarova, Marketa, et al.
Publicado: (2016)

Immunosuppressive treatment in fulminant myocarditis and gene expression pattern associated with, but no histological confirmation of giant cell myocarditis
por: Fruhwald, Friedrich, et al.
Publicado: (2017)

Heart failure after myocardial infarction: incidence and predictors
por: Jenča, Dominik, et al.
Publicado: (2020)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

FGF-23 is a biomarker of RV dysfunction and congestion in patients with HFrEF
por: Benes, Jan, et al.
Publicado: (2023)

Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report
por: Zhou, Chi
Publicado: (2023)

Successful Treatment of Cardiogenic Shock Due to Takotsubo Cardiomyopathy With Left Ventricular Outflow Tract Obstruction and Acute Mitral Regurgitation by Impella CP
por: Benak, Ales, et al.
Publicado: (2022)

Dysregulation of epicardial adipose tissue in cachexia due to heart failure: the role of natriuretic peptides and cardiolipin
por: Janovska, Petra, et al.
Publicado: (2020)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Right ventricular global dysfunction score: a new concept of right ventricular function assessment in patients with heart failure with reduced ejection fraction (HFrEF)
por: Benes, Jan, et al.
Publicado: (2023)

ECMELLA as a bridge to heart transplantation in refractory ventricular fibrillation: A case report
por: Giraud, Raphaël, et al.
Publicado: (2023)

Mechanical circulatory support with ECMELLA approach in severe cardiogenic shock patients—state of the art
por: Nersesian, Gaik, et al.
Publicado: (2023)

Do Genes Influence Susceptibility to Myocarditis?
por: Cooper, Leslie T., et al.
Publicado: (2021)

Mode-of-action of the PROPELLA concept in fulminant myocarditis
por: Spillmann, Frank, et al.
Publicado: (2019)

Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017)

Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Immune-mediated mechanism in coronavirus fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_denriv479vdu0s2lebkvn102km